Condition

Vaginal Atrophy

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 11 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials11
Recruiting1
Common interventions21
Lead sponsors shown11
Advertisement

Clinical trials

11 shown
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize TrialNCT05379153 · 2026-04-21
RECRUITING
Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIVNCT07526948 · 2026-09-01
NOT_YET_RECRUITING
Laser Treatment of Genito-urinary Syndrome in WomenNCT03238053 · 2022-10-01
WITHDRAWN
Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase InhibitorsNCT04493333 · 2021-06-07
TERMINATED
Accelerated Genital Tract Aging in HIV: Estradiol Clinical TrialNCT04079218 · 2020-09-01
COMPLETED
Histological Modifications of Postmenopausal Vaginal Mucosa After Repeated Carbon Dioxide (CO2) Laser TreatmentNCT04868812 · 2019-12-03
COMPLETED
LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2)NCT04081805 · 2019-09-30
ACTIVE_NOT_RECRUITING
Vaginal Laser Therapy in Breast Cancer SurvivorsNCT03738605 · 2018-12-01
UNKNOWN
A Prospective Trial to Assess Breast Cancer Survivors and Vaginal Atrophy Treatment OutcomesNCT03547089 · 2018-08-01
SUSPENDED
A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant SettingNCT02413008 · 2015-10-16
COMPLETED
Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer PatientsNCT00607295 · 2007-12-01
COMPLETED

Common interventions

Trial status mix

COMPLETED4
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
RECRUITING1
SUSPENDED1
TERMINATED1
UNKNOWN1
WITHDRAWN1

Phase mix

NA5
PHASE22
PHASE32
PHASE42
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.